CN102697868A - Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis - Google Patents
Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis Download PDFInfo
- Publication number
- CN102697868A CN102697868A CN2012100004520A CN201210000452A CN102697868A CN 102697868 A CN102697868 A CN 102697868A CN 2012100004520 A CN2012100004520 A CN 2012100004520A CN 201210000452 A CN201210000452 A CN 201210000452A CN 102697868 A CN102697868 A CN 102697868A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- urticaria
- lupus erythematosus
- immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis and called skin disease therapeutic drug No. one. The medicine comprises glossy ganoderma, ginseng, epimedium, astragalus, polygonum cuspidatum, cordyceps sinensis, kuh-seng and liquorice. The medicine is prepared by pure traditional Chinese medicine, has functions of regulating and improving human immunity, anti-bacterium and itching relieving effect, curing various skin diseases such as lupus erythematosus, urticaria and psoriasis, and has the advantages of fine therapeutic effect, low side effect, short treatment course, effectiveness and high cure rate.
Description
[technical field]
The present invention relates to a kind of pharmaceutical formulation, relate in particular to a kind of a kind of immunity of regulating that can treat multiple disease simultaneously and cure lupus erythematosus, urticaria, psoriatic medicine.
[background technology]
In process is cured the disease in present clinical application, generally all be to be main with the single relatively medicine of function, can not satisfy the requirement of the multiple disease of treatment.And because existing medicine a multitude of names, general patient is difficult to select the medicine treatment according to self disease oneself.
In addition, it is Western medicine greatly that existing medicine has, and not only expensive makes general ordinary people be difficult to bear, and has toxic and side effects usually, and patient is long-term or take in a large number and can cause the human body viscera damage and develop immunity to drugs, thoroughly radical curing of disease.Some people also can produce the phenomenon of vomiting when taking Western medicine, thereby has increased patient's misery.
In this case, people turn to the traditional Chinese medical science to the hope of treatment.Yet, the medicine that still unmatchful multiple disease can be treated simultaneously in the traditional Chinese medical science at present.
Therefore, for avoiding the problems referred to above, necessaryly provide a kind of and can regulate body immunity, cure lupus erythematosus and psoriatic Chinese patent medicine, to overcome said defective of the prior art.
[summary of the invention]
For addressing the above problem, the object of the present invention is to provide a kind of therapeutic effect good, side effect is little, short treating period, and can treat a kind of of multiple disease simultaneously and can regulate body immunity, cure lupus erythematosus and psoriatic Chinese patent medicine.
Be to realize above-mentioned purpose, the technical scheme that the present invention takes is: a kind ofly can regulate body immunity, cure lupus erythematosus and psoriatic Chinese patent medicine, it comprises Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Radix Sophorae Flavescentis and Radix Glycyrrhizae.
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine further is: said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented): 10~14 parts of Ganodermas; 7~9 parts of Radix Ginsengs; 15~20 parts of Herba Epimedii; 9~11 parts of the Radixs Astragali; 10~12 parts of Rhizoma Polygoni Cuspidati; 6~8 parts of Cordycepses; 11~15 parts of Radix Sophorae Flavescentiss; 11~15 parts in Radix Glycyrrhizae.
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine further is: said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts of Cordycepses; 12 parts of Radix Sophorae Flavescentiss; 12 parts in Radix Glycyrrhizae.
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, psoriatic medicine can also for: said pharmaceutical formulation can be processed tablet, capsule, electuary, oral liquid or injection.
Compared with prior art, the present invention has following beneficial effect: a kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine is that pure Chinese medicine is processed, and it is good to have a therapeutic effect, and side effect is little, plurality of advantages such as short treating period; The effect of body immunity and anti-bacterial, anti-itching is regulated and improved to tool.Various dermatosiss such as treatment lupus erythematosus, psoriasis, eczema, urticaria.The high characteristics of instant effect cure rate are arranged.。
[specific embodiment]
Below in conjunction with embodiment the present invention is done further explanation.
Embodiment 1:
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine is made up of following Chinese medicine: Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Radix Sophorae Flavescentis and Radix Glycyrrhizae.Wherein, said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented): 10~14 parts of Ganodermas; 7~9 parts of Radix Ginsengs; 15~20 parts of Herba Epimedii; 9~11 parts of the Radixs Astragali; 10~12 parts of Rhizoma Polygoni Cuspidati; 6~8 parts of Cordycepses; 11~15 parts of Radix Sophorae Flavescentiss; 11~15 parts in Radix Glycyrrhizae.Said pharmaceutical formulation is processed tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
Embodiment 2:
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine is made up of following Chinese medicine: Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Radix Sophorae Flavescentis and Radix Glycyrrhizae.Wherein, said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts of Cordycepses; 12 parts of Radix Sophorae Flavescentiss; 12 parts in Radix Glycyrrhizae.Said pharmaceutical formulation is processed tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine is that pure Chinese medicine is processed, and it is good to have a therapeutic effect, and side effect is little, plurality of advantages such as short treating period; The effect of body immunity and anti-bacterial, anti-itching is regulated and improved to tool.Various dermatosiss such as treatment lupus erythematosus, psoriasis, eczema, urticaria.The high characteristics of instant effect cure rate are arranged.
The above specific embodiment is merely the preferred embodiment of this creation, not in order to limiting this creation, any modification of being made within all spirit and principles in this creation, is equal to replacement, improvement etc., all should be included within the protection domain of this creation.
Claims (4)
1. can regulate immunity healing lupus erythematosus for one kind, urticaria, psoriatic medicine is characterized in that: comprise Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Radix Sophorae Flavescentis and Radix Glycyrrhizae.
2. a kind of immunity of regulating as claimed in claim 1 is cured lupus erythematosus, urticaria, and psoriatic medicine is characterized in that: said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented):
10~14 parts of Ganodermas;
7~9 parts of Radix Ginsengs;
15~20 parts of Herba Epimedii;
9~11 parts of the Radixs Astragali;
10~12 parts of Rhizoma Polygoni Cuspidati;
6~8 parts of Cordycepses;
11~15 parts of Radix Sophorae Flavescentiss;
11~15 parts in Radix Glycyrrhizae.
3. a kind of immunity of regulating as claimed in claim 2 is cured lupus erythematosus, urticaria, and psoriatic medicine is characterized in that: said Ganoderma; Radix Ginseng, Herba Epimedii, the Radix Astragali; Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts of Cordycepses; 12 parts of Radix Sophorae Flavescentiss; 12 parts in Radix Glycyrrhizae.
4. a kind of immunity of regulating as claimed in claim 3 is cured lupus erythematosus, urticaria, and psoriatic medicine is characterized in that: said pharmaceutical formulation can be processed tablet, capsule, electuary, oral liquid or injection.The effect of body immunity and anti-bacterial, anti-itching is regulated and improved to tool.Various dermatosiss such as treatment lupus erythematosus, psoriasis, eczema, urticaria.The high characteristics of instant effect cure rate are arranged.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100004520A CN102697868A (en) | 2012-01-04 | 2012-01-04 | Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100004520A CN102697868A (en) | 2012-01-04 | 2012-01-04 | Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102697868A true CN102697868A (en) | 2012-10-03 |
Family
ID=46891115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100004520A Pending CN102697868A (en) | 2012-01-04 | 2012-01-04 | Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102697868A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013177944A1 (en) * | 2012-05-29 | 2013-12-05 | 江中药业股份有限公司 | Use of composition in preparing health care products or medicines for preventing and treating allergic diseases |
CN105213925A (en) * | 2015-11-10 | 2016-01-06 | 王庆阳 | A kind ofly treat medicine of scalp psoriasis pustulosa and preparation method thereof |
CN105748571A (en) * | 2014-12-19 | 2016-07-13 | 烟台宝备生物技术有限公司 | Drug or health food with immunity enhancing effect |
CN107854576A (en) * | 2017-11-27 | 2018-03-30 | 江苏辉腾环保科技有限公司 | A kind of antipsoriatics thing component and preparation method thereof |
CN110404012A (en) * | 2019-08-22 | 2019-11-05 | 郑奎 | A kind of Chinese materia medica preparation and preparation method thereof with bacteriostasis |
-
2012
- 2012-01-04 CN CN2012100004520A patent/CN102697868A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013177944A1 (en) * | 2012-05-29 | 2013-12-05 | 江中药业股份有限公司 | Use of composition in preparing health care products or medicines for preventing and treating allergic diseases |
US10086030B2 (en) | 2012-05-29 | 2018-10-02 | Jiangzhong Pharmaceutical Co., Ltd. | Use of composition in preparing health care products or medicines for preventing and treating allergic diseases |
CN105748571A (en) * | 2014-12-19 | 2016-07-13 | 烟台宝备生物技术有限公司 | Drug or health food with immunity enhancing effect |
CN105213925A (en) * | 2015-11-10 | 2016-01-06 | 王庆阳 | A kind ofly treat medicine of scalp psoriasis pustulosa and preparation method thereof |
CN107854576A (en) * | 2017-11-27 | 2018-03-30 | 江苏辉腾环保科技有限公司 | A kind of antipsoriatics thing component and preparation method thereof |
CN110404012A (en) * | 2019-08-22 | 2019-11-05 | 郑奎 | A kind of Chinese materia medica preparation and preparation method thereof with bacteriostasis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102697942A (en) | Medicament capable of killing cancer cells and curing various tumors and cancers and leukemia | |
CN102247541A (en) | Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma | |
CN102697868A (en) | Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis | |
CN102697898A (en) | Medicament for regulating endocrine and curing dysmenorrheal, mammary gland hyperplasia and breast dysplasia | |
CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
CN102343038A (en) | Medicament for treating cerebrosis such as hemiplegic cerebral palsy, falling sickness, Parkinson, headache, insomnia and the like | |
CN102327493A (en) | Medicine for treating tracheitis, rhinitis, pharyngitis, pneumonectasis, pulmonary heart diseases and asthmatic diseases | |
CN104306846A (en) | Traditional Chinese medicine for treating attention deficit hyperactivity disorder | |
CN103372083A (en) | Chinese medicinal composition for treating spontaneous perspiration | |
CN102670817A (en) | Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia | |
CN102423359A (en) | Drug for restoring renal functions and curing various nephrosis such as nephritis, uremia and the like | |
CN104398915A (en) | Traditional Chinese medicinal composition for chronic eczema | |
CN101468189A (en) | Chinese medicine for treating rhinitis | |
CN102327492A (en) | Medicine for treating amyotrophia and myasthenia, myodystrophy and motor neuron injury | |
CN102343039A (en) | Drug for treating skin diseases such as psoriasis, leucoderma, ichthyosis, eczema and the like | |
CN102327491A (en) | Medicine for treating venereal diseases, such as prostatosis, condyloma acuminatum, gonorrhea syphilis and aids | |
CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
CN102343042A (en) | Medicine for treating cardiovascular diseases of hypertension, cardiopathy and cerebral thrombus | |
CN102343040A (en) | Drug for treating otitis media, deaf and tinnitus | |
CN102343037A (en) | Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay | |
CN103520289A (en) | Chinese medicinal composition for treating constipation, preparation method and application thereof | |
CN102697869A (en) | Medicine capable of regulating blood surger level, restoring pancreatic function and curing diabetes mellitus | |
CN102125653A (en) | Anti-inflammatory antitussive medicine | |
CN105770548A (en) | Externally-used traditional Chinese medicine for treating skin eczema | |
CN102430007A (en) | Weight-losing Chinese patent medicine capable of eliminating fat and treating fatty liver obesity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C05 | Deemed withdrawal (patent law before 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121003 |